Physician profile
Mudar Dalloul
NPI 1053307348
$1,830.16
in general payments reported to CMS, 2019-2025
17 companies · $96.31 in 2025
The $96.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $273 · 2021: $139 · 2023: $145 · 2024: $52.27 · 2025: $96.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,118.26 | 2019-2023 | Jardiance |
| Medical Device Business Services, INC. | $325.00 | 2019 | |
| Tesaro, INC. | $70.93 | 2019 | |
| Eisai INC. | $46.72 | 2019-2020 | |
| Roche Diagnostics Corporation | $40.18 | 2019-2025 | Cobas Liat Analyzer |
| Viiv Healthcare Company | $34.49 | 2025 | |
| Pfizer INC. | $27.43 | 2024 | |
| Organon LLC | $24.84 | 2024 | |
| Hologic Sales and Service, LLC | $24.29 | 2025 | Aptima |
| Shield Therapeutics INC | $22.35 | 2025 | |
| Clovis Oncology, INC. | $21.05 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.44 | 2023 | |
| Masimo Corporation | $17.51 | 2019 | |
| Coopersurgical, INC. | $14.17 | 2021 | |
| Merck Sharp & Dohme LLC | $11.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $11.02 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mudar Dalloul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.